Key Takeaways
- The National Biotechnology Research and Development Agency reassures Nigerians on the health safety of genetically modified organisms (GMOs).
- The agency commits to evidence-based engagement to counter misinformation about GMOs.
- Strict biosafety regulations ensure that no GMO product can enter circulation without thorough approval in Nigeria.
Commitment to Safety
The National Biotechnology Research and Development Agency (NBRDA) has stated its assurance regarding the health safety of genetically modified organisms (GMOs) in Nigeria. Director-General Abdullahi Mustapha emphasized this assurance in a statement, aiming to address ongoing debates fueled by misinformation surrounding GMOs.
Mr. Mustapha highlighted the agency’s commitment to combat ignorance through research-driven advocacy and community engagement. “Our top priority is the well-being of Nigerians. We will never compromise public health or safety in the pursuit of innovation,” he declared.
He noted that GMOs are globally recognized as safe for both human health and the environment. The approval process for GMOs in Nigeria is strictly governed by biosafety regulations established by the National Biosafety Management Agency (NBMA). Mustapha explained that no GMO product is permitted in circulation without complete and rigorous assessment by the NBMA.
Addressing concerns about GMOs, he stated, “Around the world, they have been researched for decades, regulated by rigorous international standards.” This focus on safety is underscored by the agency’s comprehensive risk assessments required for approval.
Furthermore, the NBRDA is making concerted efforts to engage various stakeholders—including farmers, policymakers, scientists, youth, and civil society—on the importance of biotechnology. Through various initiatives such as training sessions, community outreach efforts, open discussions, and field demonstrations, the agency is working to rebuild public confidence in biotechnology while countering the spread of misinformation with factual data.
In conclusion, the NBRDA remains dedicated to promoting innovative research across sectors while ensuring that public health and safety are never compromised in the advancement of biotech solutions.
The content above is a summary. For more details, see the source article.